Today's session produced a sweeping rally across genomics, medical-device, data-security, and healthcare-services names. 10x Genomics ( Nasdaq : TXG) surged nearly 13%, Butterfly Network (NYSE: BFLY), Rubrik (NYSE: RBRK), and LifeStance Health (NASDAQ: LFST) all gained more than 10%, and RadNet (NASDAQ: RDNT) added a further 6.79%. Volume was heavy across the group, with several names breaking decisively to fresh highs after multi-month uptrends or basing patterns.

10x Genomics, Inc. (NASDAQ: TXG) — Explosive Breakout to Fresh Highs

Key Highlights

  • TXG trading at $58.69, up 12.79% ($6.66) on volume of 3.17M shares, after ranging between $50.81 and $59.00 on an open at $51.91.
  • Price has surged well above both the 20-day EMA ($47.02) and the 50-day EMA ($40.57), extending a powerful uptrend to new highs.
  • RSI has spiked to roughly 75.30, with the signal line at 65.86 — a move deep into overbought territory.
  • TXG spent late 2025 basing in the mid-teens, then climbed steadily through a choppy 2026 range between roughly $18 and $28 before an accelerating breakout from May onward carried the stock to today's fresh highs.
  • Today's gain is the largest single-day move on the chart since the uptrend began accelerating in May.

Trend Structure TXG's chart shows a long, quiet base through late 2025, followed by a gradual climb through a choppy range in early 2026. From May onward the stock has been in a steady, accelerating uptrend, and today's session extends that move to fresh highs on the heaviest conviction yet.

Key Technical Levels Resistance

  • ~$60.00 – Psychological round-number level / today's high area
  • No prior chart resistance meaningfully overhead; the stock is testing new highs

Support

  • $47.02 – 20-day EMA
  • ~$50.00 – Recent breakout shelf
  • $40.57 – 50-day EMA

Outlook TXG's breakout is a decisive technical development, and the stock remains well above both EMAs after a sustained multi-month climb. The deeply overbought RSI raises the risk of near-term consolidation; holding above $50 on any pullback would keep the uptrend intact.

Butterfly Network, Inc. (NYSE: BFLY) — Fresh Highs on a Persistent Multi-Month Climb

Key Highlights

  • BFLY trading at $9.79, up 10.82% ($0.96) on volume of 8.76M shares, after ranging between $8.83 and $10.05 on an open at $8.84.
  • Price has extended well above both the 20-day EMA ($7.90) and the 50-day EMA ($7.07), continuing a steady uptrend that has been in place for months.
  • RSI has climbed to roughly 67.17, with the signal line at 55.16 — a firm move into bullish territory.
  • BFLY rallied steadily from roughly $2 in late 2025 to a June 2026 spike near $9.50, corrected into a July low near $7, and has since recovered to press to fresh highs today.
  • Today's gain is among the largest single-day moves on the chart since the June spike.

Trend Structure BFLY's chart shows a persistent, well-supported uptrend from late 2025 through mid-2026, punctuated by a sharp June spike and a subsequent pullback. Today's session breaks the stock out to fresh highs, extending the underlying uptrend.

Key Technical Levels Resistance

  • ~$10.00 – Psychological round-number level / today's high area
  • No prior chart resistance meaningfully overhead; the stock is testing new highs

Support

  • $7.90 – 20-day EMA
  • ~$8.00 – Recent breakout shelf
  • $7.07 – 50-day EMA

Outlook BFLY's breakout to fresh highs keeps the multi-month uptrend intact. Holding above $8 on any pullback would confirm the move has staying power; a fade back into the summer range would suggest today's gain needs more time to be digested.

Rubrik, Inc. (NYSE: RBRK) — Sharp Breakout Above a Multi-Month Recovery Range

Key Highlights

  • RBRK trading at $99.79, up 10.79% ($9.72) on volume of 3.74M shares, after ranging between $90.00 and $99.93 on an open at $90.82.
  • Price has surged well above both the 20-day EMA ($80.86) and the 50-day EMA ($76.33), clearing the top of a range that had capped the stock since June.
  • RSI has spiked to roughly 76.30, with the signal line at 51.33 — a sharp move deep into overbought territory.
  • RBRK declined from a September 2025 high near $105 into a February 2026 low near $48, then staged a steady recovery through the spring and summer, consolidating in a roughly $75-$90 range before today's decisive breakout.
  • Today's gain is the largest single-day move on the chart since the February low.

Trend Structure RBRK's chart shows a sustained decline from a September 2025 peak into a February 2026 low, followed by a steady, well-supported recovery through the spring and summer. Today's session clears the top of a multi-month consolidation range on heavy volume.

Key Technical Levels Resistance

  • ~$100.00 – Psychological round-number level / today's high area
  • No prior chart resistance meaningfully overhead beyond that level

Support

  • $80.86 – 20-day EMA
  • ~$88.00 – Top of the recent range (former resistance, now support)
  • $76.33 – 50-day EMA

Outlook RBRK's breakout is a decisive technical development after a long recovery process, though the extreme RSI reading raises the risk of near-term consolidation. A hold above $88 on any retest would confirm the breakout has staying power; a fast fade back into the prior range would suggest today's move needs more time to digest.

LifeStance Health Group, Inc. (NASDAQ: LFST) — Breaking Out of a Summer Consolidation Range

Key Highlights

  • LFST trading at $11.99, up 10.61% ($1.15) on volume of 8.06M shares, after ranging between $10.85 and $12.43 on an open at $10.85.
  • Price has broken above both the 20-day EMA ($10.79) and the 50-day EMA ($10.04), clearing the top of a range that had contained the stock since June.
  • RSI has climbed to roughly 68.28, with the signal line at 55.28 — a firm move into bullish territory.
  • LFST rallied steadily from roughly $5 in late 2025 to a July 2026 high near $11.50, then consolidated in a roughly $10-$11.50 range before today's decisive breakout to fresh highs.
  • Today's gain is among the largest single-day moves on the chart since the spring uptrend phase.

Trend Structure LFST's chart shows a steady, persistent uptrend from a late-2025 base through mid-2026, followed by a multi-week consolidation just below the July highs. Today's session clears that range on heavy volume, pushing the stock to fresh highs.

Key Technical Levels Resistance

  • ~$12.50 – Today's intraday high area
  • No prior chart resistance meaningfully overhead; the stock is testing new highs

Support

  • $10.79 – 20-day EMA
  • ~$11.00 – Top of the recent range (former resistance, now support)
  • $10.04 – 50-day EMA

Outlook LFST's breakout clears a range that had constrained the stock for weeks. A hold above $11 on any retest would confirm the breakout has staying power; a fade back into the prior range would suggest today's move needs more time to be digested.

RadNet, Inc. (NASDAQ: RDNT) — Strong Recovery Approaching Late-2025 Highs

Key Highlights

  • RDNT trading at $77.30, up 6.79% ($4.91) on volume of 1.1M shares, after ranging between $69.81 and $78.86 on an open at $73.03.
  • Price has extended well above both the 20-day EMA ($66.04) and the 50-day EMA ($62.77), continuing a steady multi-month recovery.
  • RSI has climbed to roughly 75.39, with the signal line at 58.32 — a sharp move deep into overbought territory.
  • RDNT declined from a November 2025 high near $85 into an April 2026 low near $52, then staged a steady recovery through the summer that has accelerated over the past several sessions.
  • Today's gain is among the largest single-day moves on the chart since the recovery began in April.

Trend Structure RDNT's chart shows a sustained decline from a November 2025 peak into an April 2026 low, followed by a gradual, choppy recovery that has picked up pace through July and August. Today's session extends that move to the stock's best levels since last November.

Key Technical Levels Resistance

  • ~$80.00 – November 2025 high area
  • ~$85.00 – November 2025 peak

Support

  • $66.04 – 20-day EMA
  • ~$70.00 – Recent breakout shelf
  • $62.77 – 50-day EMA

Outlook RDNT's recovery is approaching a key test at the November 2025 highs, and the deeply overbought RSI raises the risk of a near-term pause. A close above $80 would open a path toward retesting the $85 peak; a fade back below $70 would suggest the rally needs more time to consolidate.

This analysis is based on Daily Chart technical indicators (20/50-day EMAs, RSI-14) and price action as of August 10, 2026, and is intended for informational purposes only — not Investment advice.